By exploiting dual specificity to ever greater effect, bispecific antibodies expand possibilities for Treg depletion, checkpoint inhibition, and targeted toxicity.
By exploiting dual specificity to ever greater effect, bispecific antibodies expand possibilities for Treg depletion, checkpoint inhibition, and targeted toxicity.
"Brief" is the official University of Minnesota news digest for faculty and staff and is sent to University employees statewide. Publication is every Wednesday during the academic terms. "Brief" began publication October 6, 1970.
/PRNewswire/ Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and development in immuno-oncology, announced today.